Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$452M |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$359M |
| 3 |
Accenture
ACN
|
+$329M |
| 4 |
Becton Dickinson
BDX
|
+$318M |
| 5 |
Coca-Cola
KO
|
+$269M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$517M |
| 2 |
Chevron
CVX
|
+$454M |
| 3 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$429M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$355M |
| 5 |
Dollar Tree
DLTR
|
+$348M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.79% |
| 2 | Financials | 11.74% |
| 3 | Healthcare | 10.79% |
| 4 | Consumer Discretionary | 8.84% |
| 5 | Industrials | 8.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
iShares Russell Mid-Cap ETF
IWR
$56.1B
| $557M | 0.17% |
7,029,560
+544,105
| +8% | +$42.2M |
|
127
American Express
AXP
$228B
| $553M | 0.17% |
3,347,048
+172,544
| +5% | +$27M |
|
128
Vanguard Morningstar Small-Cap ETF
VB
$79.6B
| $553M | 0.17% |
2,455,735
-288,242
| -11% | -$63.9M |
|
129
Vertex Pharmaceuticals
VRTX
$122B
| $552M | 0.17% |
2,738,775
+820,708
| +43% | +$172M |
|
130
NXP Semiconductors
NXPI
$61.8B
| $551M | 0.17% |
2,677,849
-498,154
| -16% | -$99.8M |
|
131
iShares 0-5 Year TIPS Bond ETF
STIP
$15.9B
| $548M | 0.17% |
5,330,288
+700,512
| +15% | +$74.4M |
|
132
Vanguard Morningstar Total Stock Market ETF
VTI
$657B
| $548M | 0.17% |
2,452,957
+367,369
| +18% | +$79.7M |
|
133
BioMarin Pharmaceuticals
BMRN
$11.7B
| $547M | 0.17% |
6,550,249
+316,914
| +5% | +$25.1M |
|
134
TSMC
TSM
$2.09T
| $539M | 0.17% |
4,487,169
+294,375
| +7% | +$34.5M |
|
135
State Street
STT
$50.2B
| $534M | 0.17% |
6,488,199
+270,018
| +4% | +$22.8M |
|
136
Digital Realty Trust
DLR
$71.5B
| $529M | 0.16% |
3,511,859
+115,995
| +3% | +$17.5M |
|
137
Edwards Lifesciences
EW
$50B
| $524M | 0.16% |
5,064,415
+33,525
| +0.7% | +$3.16M |
|
138
IQVIA
IQV
$39.1B
| $519M | 0.16% |
2,142,253
+977,071
| +84% | +$226M |
|
139
Northern Trust
NTRS
$22.4B
| $517M | 0.16% |
4,473,853
+115,108
| +3% | +$13.2M |
|
140
iShares Core S&P Mid-Cap ETF
IJH
$122B
| $516M | 0.16% |
9,590,065
+756,060
| +9% | +$40.8M |
|
141
DTE Energy
DTE
$29.5B
| $507M | 0.16% |
4,605,322
+987,798
| +27% | +$116M |
|
142
Advanced Micro Devices
AMD
$791B
| $493M | 0.15% |
5,250,999
+2,016,206
| +62% | +$163M |
|
143
iShares Core MSCI EAFE ETF
IEFA
$192B
| $493M | 0.15% |
6,587,254
+1,508,447
| +30% | +$114M |
|
144
Stryker
SYK
$133B
| $489M | 0.15% |
1,883,675
+121,078
| +7% | +$31M |
|
145
Vanguard Information Technology ETF
VGT
$139B
| $483M | 0.15% |
9,697,776
-508,912
| -5% | -$24M |
|
146
iShares MSCI USA Min Vol Factor ETF
USMV
$23.5B
| $474M | 0.15% |
6,439,072
+659,871
| +11% | +$47.7M |
|
147
Oracle
ORCL
$367B
| $474M | 0.15% |
6,085,681
-1,511,599
| -20% | -$118M |
|
148
Corning
GLW
$116B
| $472M | 0.15% |
11,493,517
-539,151
| -4% | -$23.5M |
|
149
Humana
HUM
$44B
| $464M | 0.14% |
1,046,944
-214,696
| -17% | -$93.8M |
|
150
Stanley Black & Decker
SWK
$14.9B
| $462M | 0.14% |
2,252,620
-31,247
| -1% | -$6.48M |
|
Similar funds
Ameriprise's Q2 2021 Portfolio in Review
As of Q2 2021, Ameriprise held 4,059 positions worth $323B, up 7.5% from $301B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Ameriprise's Q2 2021 filing shows 217 new, 1,727 increased, 1,816 reduced and 179 closed positions. Its largest new stake was NiSource Inc. Series A Corporate Units: 830,300 shares worth $85.5M. The largest sale was UnitedHealth, an estimated $517M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- Ameriprise's largest Q2 2021 buy was NiSource Inc. Series A Corporate Units: 830,300 shares worth $85.5M.
- Ameriprise added most to ExxonMobil in Q2 2021, an estimated $452M increase.
- Ameriprise's biggest Q2 2021 reduction was UnitedHealth, cutting an estimated $517M.
- Ameriprise fully exited INPHI CORPORATION in Q2 2021, selling an estimated $139M.
- Ameriprise's ten largest holdings make up 15% of its $323B portfolio in Q2 2021.
- Ameriprise opened 217 new positions and closed 179 in Q2 2021.
- Ameriprise's portfolio value rose 7.5% quarter-over-quarter to $323B.
Based on Ameriprise's 13F filing for Q2 2021, filed 16 Aug 2021.